These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3965701)
21. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists. Ringdahl B J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881 [TBL] [Abstract][Full Text] [Related]
22. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide. Ringdahl B; Ehler FJ; Jenden DJ Mol Pharmacol; 1982 May; 21(3):594-9. PubMed ID: 6125875 [TBL] [Abstract][Full Text] [Related]
23. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations. Ladner CJ; Lee JM Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152 [TBL] [Abstract][Full Text] [Related]
24. Dissociation constants and relative efficacies of acetylcholine, (+)- and (-)-methacholine at muscarinic receptors in the guinea-pig ileum. Ringdahl B Br J Pharmacol; 1986 Sep; 89(1):7-13. PubMed ID: 3801779 [TBL] [Abstract][Full Text] [Related]
25. A snake venom phospholipase A2 with high affinity for muscarinic acetylcholine receptors acts on guinea pig ileum. Huang LF; Zheng JB; Xu Y; Song HT; Yu CX Toxicon; 2008 May; 51(6):1008-16. PubMed ID: 18281071 [TBL] [Abstract][Full Text] [Related]
26. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine. Ringdahl B; Katz ED; Roch M; Jenden DJ J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331 [TBL] [Abstract][Full Text] [Related]
27. Dimethylsulfonium and thiolanium analogues of the muscarinic agent oxotremorine. Ringdahl B J Med Chem; 1988 Jan; 31(1):164-8. PubMed ID: 3336015 [TBL] [Abstract][Full Text] [Related]
28. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors. Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784 [TBL] [Abstract][Full Text] [Related]
29. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists. Michal P; Lysíková M; Tucek S Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872 [TBL] [Abstract][Full Text] [Related]
30. Antagonism by imidazoline-type drugs of muscarinic and other receptors in the guinea-pig ileum. Salazar-Bookaman MM; Miller DD; Patil PN Auton Autacoid Pharmacol; 2006 Jul; 26(3):267-73. PubMed ID: 16879492 [TBL] [Abstract][Full Text] [Related]
31. Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine. Fisher SK; Figueiredo JC; Bartus RT J Neurochem; 1984 Oct; 43(4):1171-9. PubMed ID: 6088696 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the stimulant activities of oxotremorine analogues on the frog rectus abdominis and the guinea pig ileum. Ringdahl B Eur J Pharmacol; 1984 Mar; 99(2-3):177-84. PubMed ID: 6234180 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine. Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539 [TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice. Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029 [TBL] [Abstract][Full Text] [Related]
35. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Nilsson BM; Vargas HM; Hacksell U J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212 [TBL] [Abstract][Full Text] [Related]
36. Muscarinic activity of some secondary and tertiary amines and quaternary ammonium salts structurally related to oxotremorine. Resul B; Ringdahl B; Dahlbom R; Jenden DJ Eur J Pharmacol; 1983 Mar; 87(4):387-96. PubMed ID: 6852095 [TBL] [Abstract][Full Text] [Related]
37. Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones. Amstutz R; Ringdahl B; Karlén B; Roch M; Jenden DJ J Med Chem; 1985 Dec; 28(12):1760-5. PubMed ID: 2933518 [TBL] [Abstract][Full Text] [Related]
38. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor. Sykes DA; Dowling MR; Charlton SJ Mol Pharmacol; 2009 Sep; 76(3):543-51. PubMed ID: 19498041 [TBL] [Abstract][Full Text] [Related]
39. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911 [TBL] [Abstract][Full Text] [Related]